Therapy with direct acting antivirals including ledipasvir is related to really negligible Unwanted side effects, with the commonest currently being headache and fatigue . Insufficient major Unwanted side effects and brief duration of therapy is a substantial edge around older interferon- and ribavirin-dependent regimens, which have been limited by